Save to favorites
This feature is restricted to active members.
Join now to save favorites and get all member benefits, including over 1,400 reviews.
Join NowAlready a member? Sign in here.
Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted November 03, 2022
Seller of CBD Warned for COVID-19 Claims
On November 1, 2022, the FDA issued a warning letter to Alternative Health Distribution LLC (d/b/a CannaAid) following a review of the company’s website, which found statements about the company’s cannabidiol (CBD) products to be drug claims.
The company’s CBD products were promoted with statements such as, “Recent analyses from numerous preliminary in vitro and animal studies have shown that cannabinoids in hemp, specifically CBD, can significantly reduce COVID-19’s ability to infect new cells – limiting inflammation in the lungs and possibly improving a patients’ quality of life during severe COVID-19 infection.” Its Immune Plus tincture was promoted with statements such as, “Here at CannaAid, we provide the best in what’s wellness. If you’re interested in trying CBD to mitigate the flu-like symptoms, check our online selection to find what best fits your needs — our Immune Plus tincture is a 4,200 mg. proprietary wellness blend made with CBGa and CBDa that just may do the trick!”
The company must respond to the agency within 15 days of receipt of the letter outlining any steps to address any violations.
For more information and tests of related products, see ConsumerLab’s CBD Review. Also see Do any supplements help with coronavirus (COVID-19)? Do supplements like vitamin D, zinc, vitamin C, or herbals work?
For more information, use the link below.
Warning: Alternative Health Distribution LLC d/b/a CannaAid
See related recalls and warnings:
Seller of CBD Warned for COVID-19 Claims
CBD Products Were Promoted to Treat Cancer and Alzheimer’s Without Proof, Says FTC
Maker of Care by Design CBD Settles Charges of Unsupported Claims
CBD Seller Warned for Drug and COVID-19 Claims
FDA Warns Five Companies for Selling CBD Supplements, Gummies and Creams with Delta-8 THC
Report a Problem
If you have experienced an unexpected and adverse reaction to a dietary supplement, nutritional product, or generic drug, we would like to hear about it, as we may investigate the problem. Please select from one of these options:
Dietary Supplement or Nutritional Product Problem Report
If you believe that a dietary supplement (e.g., vitamin, mineral, or herbal supplement) or other nutritional product has caused an unexpected, adverse reaction, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their Safety Reporting Portal at https://www.safetyreporting.hhs.gov.
Please complete the form below as accurately as possible. You may need to check the label on the product.
Thank you for submitting your report.
Generic Drug Problem Report
If you believe that a generic drug has not acted like the original drug, we would like to know about it. We are collecting and organizing this information and may publish it. We might test the product in the future. You may also want to report the problem to the U.S. FDA through their MedWatch program at the FDA MedWatch website.
Please complete the form below as accurately as possible. You may need to check the label on the drug.
Thank you for submitting your report.
